Related Experiment Videos
The cisplatin-methotrexate neo-adjuvant protocol as first-line therapy of bladder cancer. Present experience in
G B Ingargiola1, M Lamartina, G Cassata
1Institute of Urology, University of Palermo, Italy.
Progress in Clinical and Biological Research
|January 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients.
Actas urologicas espanolas·2021
Moderate hypofractionated helical tomotherapy for prostate cancer in a cohort of older patients: a mono-institutional report of toxicity and clinical outcomes.
Aging clinical and experimental research·2019
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
Cancer treatment and research communications·2019
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature.
Critical reviews in oncology/hematology·2018
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.
World journal of urology·2018
DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.
Progress in clinical and biological research·2018
Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.
Progress in clinical and biological research·1998
The molecular basis for therapeutic concepts utilizing CD14.
Progress in clinical and biological research·1998
Endotoxin tolerance alters macrophage membrane regulatory G proteins.
Progress in clinical and biological research·1998
Molecular mechanisms responsible for endotoxin tolerance.
Progress in clinical and biological research·1998
Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
Progress in clinical and biological research·1998
Oxygen-Gradient-Responsive Photosensitizing Gadolinium Phthalocyaninate for Self-Adaptive Type II/I Photodynamic Therapy Toward Heterogeneous Tumor Suppression.
Small (Weinheim an der Bergstrasse, Germany)·2026
An Immunogenic Cell Death-Enhanced Self-Assembled Nanoparticle-Composite Hydrogel for Postoperative Local Immunotherapy of Melanoma.
Omics : a journal of integrative biology·2026